and 3 positive oral challenge results. This resulted in 81 patients being delabelled. Women were more likely than men to have a true penicillin allergy OR 4.0 (95% CI 1.23-13.2). There were no serious adverse events.
P24 DUAL EFFECT OF PHENYLEPHRINE TO IMPROVE CORONARY PERFUSION DURING ANAPHYLAXIS MANAGEMENT

Joseph S Tobias, Elizabeth Richards and Chu Woon Ng
Bundaberg Base Hospital, Queensland, Australia Introduction: Adrenaline, the drug of choice in anaphylaxis may produce side effects like tachycardia resulting in impaired coronary perfusion in the setting of severe hypotension. In this situation, Phenylephrine was used to improve coronary perfusion by Increasing coronary flow time from reflex bradycardia and an increase in coronary perfusion pressure resulting from an overall increase in systemic blood pressure.
Description:
We describe a situation where at the end of an elective high anterior resection for colovesical fistula, immediately after administering reversal agents (Neostigmine and glycopyrrolate), there was severe hypotension with systolic blood pressure of 40m mmHg unresponsive to Ephedrine and Metaraminol. Adrenaline boluses resulted in tachycardia with marked ST segment elevation and slight increase in blood pressure. Intravenous Phenylephrine 100 mcg bolus was given and repeated twice over a period of 15 minutes which reduced the heart rate from 130 to 100 beats/ minute as well as increased the blood pressure with ST segment returning to baseline. ANZAAG guidelines were followed to maximise management and team efficiency during and after the crisis and resulted in an uneventful recovery. A 10 fold increase in serum Tryptase confirmed anaphylaxis.
Discussion: Anaphylaxis to reversal agents (Neostigmine and Glycopyrrolate) is rare 1 and in this situation it was complicated by ECG evidence of tachycardia induced ST segment elevation after administration of 2 doses of 100 mcg increments of adrenaline with only small increase in blood pressure. Phenylephrine improved the myocardial perfusion and blood pressure. We recommend that Phenylephrine should be considered in the presence of Adrenaline induced tachycardia to improve myocardial perfusion during anaphylaxis management. Background: Antibiotic-associated severe cutaneous adverse reactions (AA-SCAR) are frequently associated with difficult causality assessments and compounded by the absence of reliable clinical diagnostics.
P25 THE COMBINED UTILITY OF EX VIVO IFN-γ RELEASE ENZYME LINKED IMMUNOSPOT AND IN VIVO SKIN TESTING IN PATIENTS WITH ANTIBIOTIC ASSOCIATED SEVERE CUTANEOUS ADVERSE DRUG REACTIONS
Objective: To determine the combined utility of in vivo and ex vivo diagnostic approaches at assigning drug causality in a cohort AA-SCAR patients.
Methods: Patients with AA-SCAR were prospectively recruited between April 2015 and February 2017. In vivo testing (patch test (PT) or delayed intradermal (IDT)) was performed to implicated antibiotic(s) at the highest non-irritating concentration and read at 24-h through 1 week. Ex vivo testing utilised patient peripheral blood mononuclear cells (PBMCs) stimulated with a range of pharmacologically relevant concentrations of implicated antibiotics to measure dose-dependent IFN-γ release from CD4+ and CD8+ Tcells via an enzyme linked immunoSpot (ELISpot) assay.
Results: In 19 patients with AA-SCAR, combined in vivo and ex vivo testing assigned antibiotic causality in 15 (79%) patients. Ten AA-SCAR patients (53%) were positive on IFN-γ release ELISpot, with an overall sensitivity of 52% (95% CI 29-76) and specificity of 100% (95% CI 79-100), with improved sensitivity noted in acute (within 1 day to 6 weeks after SCAR onset) testing (75%). There were higher rates of positive skin tests towards betalactams over non-beta-lactams (77% vs 22%, P = 0.05) and all glycopeptide-SCAR were identified on ex vivo testing alone (n = 6). There was increased use of narrow spectrum beta-lactams and antibiotics from within the implicated class following testing in patients with a positive ex vivo or in vivo test.
Conclusion:
In this pilot study we demonstrate the potential novel utility of combined in vivo and ex vivo testing in patients with AA-SCAR to assign drug causality, with high specificity. Such combined testing may aid antibiotic selection and appropriateness in patients with a history of severe antibiotic-associated cutaneous reactions. Background: Lack of understanding of the antigenic determinants generated by cephalosporins have hindered the development of sensitive in vitro tests for the detection of cephalosporin mediated immediate hypersensitivity reactions (IHRs) and the in vivo tests are risky. Hence, the aim of this study was to investigate the utility of the basophil activation test (BAT) to diagnose cephalosporin mediated IHR.
P26 THE UTILITY OF BASOPHIL ACTIVATION TEST IN THE DIAGNOSIS OF TYPE 1 HYPERSENSITIVITY REACTIONS MEDIATED BY CEPHALOSPORINS: SELECTIVE AND CROSS REACTIVE RESPONSES
Methods: 16 patients with at least one manifestation consistent with IHRs to cephalosporins (recent history, intra-dermal skin testing (ST) and/or DPT) and 10 non-allergic negative controls were included. The BAT was conducted using a spectrum of beta-lactams including the culprit cephalosporin. Basophils were gated using CD45+/CD123+/HLA-DR-/AECD193 + and the CD63 up-regulation (>10% as compared with the baseline) was used as the activation marker. Cross reactivity were tested using 3-8 different beta-lactams in 15 patients. The sensitivity and specificity of the BAT was compared to the findings from the clinical diagnosis.
Results: A total of 26 individuals were recruited, including 16 with at least 1 manifestation consistent with a cephalosporin mediated IHR and 10 nonallergic controls. 270 and 220 BAT were performed with various betalactams in the patient and non-patient group. 6/16 subjects were deemed clinically allergic and BAT was positive in four of them, resulting in a sensitivity of the BAT of 66.6% and specificity of 100%. There was minimal cross-reactivity demonstrated between different Cephalosporins and BAT was concordant with the DPT outcomes in all of the subjects where results were comparable. Similar profile was seen in subjects tested for penicillins.
Conclusion:
BAT is a useful adjunct in testing patients with Cephalosporin allergies. It can help choose a safe alternative drug and avoid the need for performing multiple drug provocation tests to rule out cross-reactivity.
P27 SUCCESSFUL OUTPATIENT SEQUENTIAL DESENSITISATION TO FOUR-DRUG ANTI-TUBERCULOUS REGIMEN FOLLOWING IMMEDIATE HYPERSENSITIVITY REACTION
A Wong, 1 C Swan, 2 V Ting, 3 E Cheong 2 and S Limaye
